← Leaderboards
Hui Zhang
Institute For Systems Biology
$17,655,480
Attributed
$34,061,035
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,662,063 · 10
By mechanism
U24$21,469,547 · 3
U01$8,577,871 · 2
U2C$3,663,318 · 2
P01$2,174,467 · 1
R21$776,860 · 2
Top collaborators
- Daniel W Chan22 shared
- Zhen Zhang14 shared
- Ruedi H. Aebersold4 shared
- Randall Brand3 shared
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyProteinsMass Spectrum AnalysisSpecimenBaseTissuesMalignant NeoplasmsGlycosylationSamplingProteomicsMonitorGlycoproteomicsCancer TypePost-Translational Protein ProcessingFutureReactionMortalityGlycoproteinsValidationSuccessBiological MarkersMultidisciplinaryEarly Detection Research NetworkSerum
Grant awards (49)
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,137,216
U24 · FY2025 · CA · contact PI
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs$985,366
U2C · FY2025 · CA
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$809,563
U01 · FY2025 · CA
Biomarker Development Laboratory$349,534
U2C · FY2025 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,084,866
U24 · FY2024 · CA · contact PI
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs$936,098
U2C · FY2024 · CA
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$769,085
U01 · FY2024 · CA
Biomarker Development Laboratory$334,030
U2C · FY2024 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,119,051
U24 · FY2023 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$982,438
U24 · FY2023 · CA · contact PI
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$825,499
U01 · FY2023 · CA
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs$679,564
U2C · FY2023 · CA
Biomarker Development Laboratory$378,726
U2C · FY2023 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,157,752
U24 · FY2022 · CA · contact PI
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer$391,040
U01 · FY2021 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,061,100
U24 · FY2020 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer$817,180
U01 · FY2020 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,029,264
U24 · FY2019 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer$747,630
U01 · FY2019 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,061,100
U24 · FY2018 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer$543,365
U01 · FY2018 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,059,750
U24 · FY2017 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer$549,721
U01 · FY2017 · CA · contact PI
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$320,842
P01 · FY2017 · HL · contact PI
Targeting Latently Infected Primary Cells using Integrated Glycoproteomics$243,000
R21 · FY2017 · AI · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cance Research$1,307,657
U24 · FY2016 · CA
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,056,780
U24 · FY2016 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer$565,219
U01 · FY2016 · CA · contact PI
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$320,842
P01 · FY2016 · HL · contact PI
Targeting Latently Infected Primary Cells using Integrated Glycoproteomics$202,500
R21 · FY2016 · AI · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,859,557
U24 · FY2015 · CA
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$302,861
P01 · FY2015 · HL · contact PI
Glycoprotein biomarkers for the early detection of aggressive prostate cancer$137,146
U01 · FY2015 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,890,981
U24 · FY2014 · CA
Glycoprotein biomarkers for the early detection of aggressive prostate cancer$391,848
U01 · FY2014 · CA · contact PI
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$303,636
P01 · FY2014 · HL · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,824,239
U24 · FY2013 · CA
Glycoprotein biomarkers for the early detection of aggressive prostate cancer$540,667
U01 · FY2013 · CA · contact PI
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$288,162
P01 · FY2013 · HL · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,875,068
U24 · FY2012 · CA
Glycoprotein biomarkers for the early detection of aggressive prostate cancer$587,230
U01 · FY2012 · CA · contact PI
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$310,124
P01 · FY2012 · HL · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,962,728
U24 · FY2011 · CA
Glycoprotein biomarkers for the early detection of aggressive prostate cancer$436,383
U01 · FY2011 · CA · contact PI
Roles of Platelet Glycoproteins and Glycans on Platelet Reactivity and Cardiovasc$328,000
P01 · FY2011 · HL · contact PI
Glycoprotein biomarkers for the early detection of aggressive prostate cancer$466,295
U01 · FY2010 · CA · contact PI
Profile serum proteins by glycopeptide capture and LC-MS$113,491
R21 · FY2006 · CA · contact PI
Profile serum proteins by glycopeptide capture and LC-MS$50,219
R21 · FY2006 · CA · contact PI
Profile serum proteins by glycopeptide capture and LC-MS$167,650
R21 · FY2005 · CA